Stoke Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Updates
Go back to Stoke Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Updates| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 240.98 -2.12 (0.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $243.10 | 52 Week High | $333.65 | |||
| Open | $242.02 | 52 Week Low | $223.02 | |||
| Day High | $243.32 | P/E | 30.86 | |||
| Day Low | $240.13 | EPS | $7.81 | |||
| Volume | 812,892 | |||||
| (NASDAQ: STOK) | Delayed: 25.68 -0.93 (3.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.61 | 52 Week High | $ | |||
| Open | $26.83 | 52 Week Low | $ | |||
| Day High | $27.22 | P/E | N/A | |||
| Day Low | $25.31 | EPS | $ | |||
| Volume | 2,257,814 | |||||



